A Rollercoaster Ride to Hope The AMT-130 Story, and What the FDA’s June 2026 Announcement Means for Our Community Our community’s first meeting with the pharmaceutical company uniQure took place in September 2018. At the time, the idea that a…
AN UPSIDE DOWN APPROACH TO CLINICAL TRIALS
SKYHAWK THERAPEUTICS AN UPSIDE DOWN APPROACH TO CLINICAL TRIALS: LEADING TO SOME EXCITING RESULTS Skyhawk Therapeutics, a US-based pharmaceutical company, has developed a new medication that aims to slow the progression of Huntington’s Disease. Let’s start from the beginning and…
